January 19th, 2007
The Buteyko method has gained worldwide recognition but it relatively new to the US. Australia, New Zealand, and countries throughout Europe such as Ireland, UK, Denmark, france, sweden, Germany, Italy etc have Buteyko practitioners available to teach this method for asthma and respiratory conditions.
Buteyko practitioner training will be commencing in Toronto in 2007 and is planned for Chicago and New York.
Self help books on this method including the best seller Asthma Free naturally and Close Your Mouth are available from many bookstores and online at www.amazon.com
Posted in Uncategorized | No Comments »
January 15th, 2007
The role of Government
In my view, our Government in general and the Department of Health in particular, are where the real problem lies, and also the only solution. The pharmaceutical industry isn’t going to change, and doctors still need research data that they feel they can trust. The old regime in Russia could make the sort of radical change that was needed because of the political system, and also because they couldn’t afford the Western approach. Remember that Russia is where the method has been most widely and most successfully used.
What is needed is independent, Government-funded research into the Buteyko Method. By Government-funded research, I mean research not funded even indirectly by pharmaceutical companies, and not influenced in any way by them either.
There is an enormous potential saving here for the national finances of hundreds of millions of euro, and that’s your money and mine. There is potentially the same saving again for asthma sufferers individually. There would be a further saving for industry in terms of less absenteeism, a development that would improve the Irish economy generally.
How much would such a research programme cost? I don’t know, but when you look at the potential savings in terms of money alone, never mind the substantial improvement in people’s basic health and quality of life, the case for research funding seems unanswerable.
I am asking people with asthma to tackle their TD and ask him or her to take it up with the Minister for Health and, equally importantly, with the Minister for Finance. Governments understand money much better than they understand health issues.
However, I predict that there will be huge resistance to the idea of allocating scarce resources to the research of hyperventilation. That resistance will come primarily from pharmaceutical companies that have large manufacturing facilities in Ireland. These companies give very good employment to substantial numbers of people and therefore have a lot of influence at Government level. They also have big PR budgets to ensure they get their message across. Multinational companies are powerful, and sometimes ruthless, entities. Asthma medication is a huge money-spinner for them and nobody likes a threat to their income. TDs with pharmaceutical plants in their constituencies will be especially vulnerable to the threat of job losses.
That being said, it’s our health and increasingly our children’s health we’re talking about. Do we really want to condemn our own children to a life of drug dependency? That is what the medication route means. Will we continue to accept the hugely expensive and spectacularly unsuccessful drug-based approach? I hope not, but I fear so.
And yet if the will is there it’s amazing what can be achieved.
The role of the individual
Even if we don’t persuade those in power to back Government-funded and independent research, what else can be done? To be more specific, what can you do? Yes, I do mean you, the individual asthma sufferer who is reading this book.
My suggestion is that when you have finished reading this book, talk to your doctor and give it a go. If you have found this book to be heavy going or if you want more information, I suggest that you contact Asthma Care and your doctor. Either way give it a try; remember, you’ve nothing to lose except your asthma problem.
However, you must be prepared to change your ways. There is a certain amount of discipline involved: you will have to do the breathing exercises, take the modest amount of physical exercise that is required, and you may have to change to a more sensible diet.
Believe me, the rewards more than justify the effort. Nothing worthwhile ever comes easy.
Posted in Uncategorized | 1 Comment »
January 12th, 2007
First, let’s take a quick look at what overbreathing is, and why we do it in the first place. Clinically, overbreathing is known as hyperventilation; put simply, it means breathing more air than the body needs. The standard volume of normal breathing for a healthy adult is three to six litres of air per minute. Scientific research conducted by Professor Buteyko over three decades, along with scientific trials at the Mater Hospital in Brisbane in 1995 demonstrated that people with asthma breathe a volume of ten to twenty litres per minute between attacks, and over twenty litres during an attack.
Overbreathing causes a loss of carbon dioxide from the lungs. This is not a problem if it occurs only for a short time, because breathing will reduce afterwards to restore the carbon dioxide levels. However, breathing more air than we need over a period of time and time can mean hours, weeks, months or even years will result in the day-to-day levels of carbon dioxide remaining low constantly. Our respiratory centre becomes accustomed to or fixed at these lower levels of carbon dioxide and determine them to be ‘correct’. Our respiratory centre will therefore instruct us to overbreathe to maintain these low levels of carbon dioxide even though the rest of our bodily organs and tissues are suffering.
Carbon dioxide is very important for normal bodily functioning (for a more detailed explanation, see Appendix 1), it is logical to assume that the body must have some way to prevent losing it. Narrowing of the airways is caused by inflammation, by constriction of smooth muscle and by increased mucus secretion, and is a natural defence mechanism to help maintain the carbon dioxide level. In a person with asthma, this defence mechanism activates when the carbon dioxide level declines too much. Overbreathing also causes cooling and drying of the airways, two effects that have been recognised to play a role in producing asthma symptoms (for a more detailed explanation, see Appendix 2).
People with asthma are better off than anyone else who overbreathes because they are equipped with an instant defence mechanism to prevent the loss of carbon dioxide. People who do not have this defence mechanism suffer from many of the diseases of civilisation for which there is no cure.
It is worth noting that before 1900, people who had asthma often lived longer than the rest of the population and that death from asthma was unknown. “Having asthma generally meant having a long life free from many diseases, but nobody could explain why asthma prevented other diseases or why asthmatics lived longer than other people,” Professor Buteyko noted. At the end of 19th century, Professor of Medicine at Oxford University Sir William Osler, wrote in his Principles and Practice of Medicine textbook: “We have no knowledge of the morbid anatomy of true asthma. Death during the attack is unknown.”
Overbreathing resulting from modern living is the cause of breathing-related diseases. Hyperventilation is not just a result of asthma, hyperventilation is the main contributor of asthma.
Professor Buteyko believes that genetic predisposition determines which illnesses people develop from overbreathing. As a result, each person who hyperventilates or overbreathes is affected individually, based on hereditary factors.
Symptoms of hyperventilation
Some of the symptoms of hyperventilation affect:
· The respiratory system in the form of wheezing, breathlessness, coughing, chest tightness, frequent yawning, snoring and sleep apnoea.
· The nervous system in the form of a light-headed feeling, poor concentration, numbness, sweating, dizziness, vertigo, tingling of hands and feet, faintness, trembling and headache,
· The heart, typically a racing heartbeat, pain in the chest region, and a skipping or irregular heartbeat.
· The mind, including some degrees of anxiety, tension, depression, apprehension and stress.
· Other general symptoms include mouth dryness, fatigue, bad dreams, nightmares, dry itchy skin, sweaty palms, increased urination such as bed wetting or regular visits to the bathroom during the night, diarrhoea, constipation, general weakness and chronic exhaustion.
Posted in Uncategorized | 2 Comments »
January 12th, 2007
There is no universally accepted definition of asthma. The Concise Oxford Dictionary describes it as “a disease of respiration characterised by difficult breathing, cough etc.”. Any good medical book will describe it in more technical terms but ‘difficult breathing’ is the part with which any asthma sufferer is familiar, even if it varies from mildly uncomfortable to life-threatening. Asthma is news now. There was a dramatic increase in the condition in the late twentieth century to the extent that an estimated 100 to 150 million people in the world are now affected by it, but it is not a recent phenomenon. (1)
The term “asthma” is a Greek translation of gasping or panting, and the problem was treated as far back as 2000 BC by Chinese doctors with the herb Ma Huang. The first known recording of the symptoms was about 3,500 years ago in an ancient Egyptian manuscript called Ebers Papyrus. Throughout the ages, asthma has received varying degrees of attention; the symptoms and their accompanying anxiety have been described by many prominent historical figures, including the famous Greek physician, Hippocrates.
Over the centuries, there has been an assortment of different theories about the causes of asthma, and so an eclectic range of remedies has been advised, including horse riding, strong coffee, tobacco, faith healing, chloroform and even drinking the blood of owls in wine, as practised by the ancient Romans. Van Helmont who lived in the early part of the seventeenth century claimed that asthma was epilepsy of the lungs due to the sudden and unpredictable nature of an attack. Based on his own experience of asthma, English physician Thomas Willis said that “the blood boils”, and that “there is scarce anything more sharp or terrible than the fits thereof”.
It was not until the eighteenth century that Lavoisier provided the first real account of the functioning of the lungs, thereby providing the basis of modern-day understanding of the respiratory system. Prior to this, it was commonly believed that air was drawn into the lungs to cool the body. Lavoisier’s contribution was that air is drawn in to be converted to energy by the metabolism, and that carbon dioxide and heat are produced as end products of the process. Lavoisier’s work recognised that oxygen is essential to sustaining life.
Asthma now affects more people throughout the world, particularly in more developed countries, than at any other time in evolution. It inflicts greater economic and social damage in Western Europe than either TB or HIV, according to the World Health Organisation’s (WHO) April 2002 report on the links between ill health in children and the deteriorating environment.
Posted in Uncategorized | No Comments »
January 12th, 2007
Buteyko practitioner and teacher training is commencing in the USA. This marks a very exciting time for Buteyko worldwide.
Asthma In the US is continuin to grow and now a well versed option of achieving measureable and notablke results over the past fifty years is available.
Buteyko International imission is to offer top class teacher training with accreditation jointly recognised by the Buteyko clinic of Moscow. It is suitable for anybody working in health related fields including Yoga practitioners, holistic therapists, medical doctors, nurses and those with a genuine interest in asthma.
Posted in Uncategorized | No Comments »
January 11th, 2007
Upcoming Webinar from Decision Resources Will Explore Using Patient-Level
Data to Quantify Lines of Therapy Within the Asthma and COPD Drug Markets
WALTHAM, Mass., Jan. 10 /PRNewswire/ — Decision Resources, one of the
world’s leading research and advisory firms focusing on pharmaceutical and
healthcare issues, finds that the use of corticosteroid inhalers will
increase for the treatment of asthma and chronic obstructive pulmonary
disease (COPD).
“Despite their criticisms of primary care physicians’ use of inhaled
corticosteroids, 39% of pulmonologists forecast that they will increase
their use of these agents for treating COPD, presumably in large part
because of the results of the TORCH study,” said Decision Resources analyst
Madhuri Borde, Ph.D. “For the treatment of asthma, physicians and experts
concur that, over the next two years, they will likely increase their use
of single-agent corticosteroid inhalers. Single-agent inhalers are becoming
seen as the most appropriate first-line agent, though Advair use in this
segment will continue to increase as well.”
The findings come from two new reports from Decision Resources:
Treatment Algorithms in Asthma and Treatment Algorithms in COPD.
Information from the reports will be presented in a webinar on January 17th
entitled “Using Patient-Level Data to Quantify Lines of Therapy within the
Asthma and COPD Markets.” For more information on how to attend the
webinar, please contact Liz Marshall of Decision Resources at 781-296-2563 .
About Treatment Algorithm Insight Series
Decision Resources combines in-depth primary research with the most
extensive claims-based longitudinal patient-level data from PharMetrics(R)
to provide exceptional insight into physicians’ prescribing trends and the
factors that drive therapy product choice, from diagnosis through multiple
courses of treatment, for a specific disease.
For each disease examined, Decision Resources’ Treatment Algorithm
Insight Series provide the following:
— Summary of U.S. medical practice based on interviews with leading
experts in the field
— Qualitative diagnosis/referral/treatment algorithm for the United
States
— Drug usage by lines of therapy (1st, 2nd, 3rd line)
— Discussion of key freeform combinations by lines of therapy
— Product share (class and specific compound level) within each line of
therapy (1st, 2nd, 3rd line)
— Progression of therapy from key 1st line products
— Pathway to key therapies from previous therapies
— Qualitative analysis of two-year forecast incorporating upcoming
launches, changes in reimbursement, etc.
The Buteyko Clinic and Asthma Care Ireland recognize the value of steroids in treating asthma. However, we also recognize how lifestyle and breathing affects our condition. Our role is to educate and inform asthmatics as to the importance of correct volume breathing. On average we expect a 50% improvement of symptoms within two weeks and a 50% decrease of medication within six months. Read the books Asthma Free naturally or Close Your Mouth to get an insight into our work. Or visit www.buteyko.ie or www.asthmacare.ie
Posted in Uncategorized | No Comments »
January 11th, 2007
By Luther Brady
t is being reported that spending time on a Florida beach, maybe very unhealthy for people with asthma. Florida red tides, occur when algae called Karenia brevis multiplies, thus polluting water, killing fish, and in some cases turning water to a brownish colour.
According to researchers, spending an hour being exposed to “red tides” can cause a 10% drop in a person’s lung function and can trigger asthmatic symptims in those people who are deemed susceptible.
“People with asthma need to be aware of their environment, particularly if they’re visiting an area with Florida red tides,” cautioned study author Dr. Lora Fleming, a professor in the departments of epidemiology, public health and marine biology and fisheries at the University of Miami Miller School of Medicine.
In the Florida study, 100 participants who all had asthma spent time on a Florida beach during “red tide” season, as well as spending time on the same beach out of “red tide” season. Tests on lung function were performed before, and after each exercise.
The study found that people did not report any sort of discomfort, nor did tests show any sort of abnormalities in lung function during the time that the participants spent on the beach out of “red tide” season. The same could not be said when participants were exposed to “red tide” as they all reported some sort of respiratory discomfort, along with a drop in lung function.
“The bottom line is, we don’t think this will put someone in the hospital, but one hour makes a measurable difference in lung function,” said Fleming.
Posted in Uncategorized | No Comments »
January 11th, 2007
MISSISSAUGA, ON, Jan. 9 /CNW/ - On your mark, get set, go!
the Ontario Lung Association, is launching an innovative educational and interactive Asthma Marathon Challenge to
demonstrate that asthma is not a barrier to living an active lifestyle. In
conjunction with the marathon challenge, AstraZeneca is also sponsoring two
up-and-coming Canadian triathlon athletes who, despite living with respiratory
dysfunction, have their sights on becoming Olympic champions at the 2008
Olympic Games.
Led by a former Olympic triathlon coach, the Asthma Marathon Challenge
will support and monitor a team of people living with asthma from across
Ontario. Twelve people will be selected to train and participate in a 5 or 10K
run at The Mississauga Marathon presented by Canon in May, leading up to the
ultimate goal of completing a full marathon at the Scotiabank Toronto
Waterfront Marathon in September.
“The goal of the marathon challenge is to raise awareness about asthma as
a manageable condition,” says Chris Haromy, Respiratory Therapist, and an
Asthma Educator with the Ontario Lung Association Asthma Action Program. “This
unique and exciting initiative will demonstrate that asthma - especially
asthma that is well controlled with a self-management plan - need not be a
barrier to achieving one’s personal or physical goals.”
THE ASTHMA MARATHON CHALLENGE
Open to Ontario adults living with asthma, teams will be formed in the
Greater Toronto Area, Ottawa, Hamilton and London. Applicants do not require
marathon or running experience, but simply the desire to dedicate the time
required to train for a marathon, and prove that asthma does not have to limit
a person. Marathon hopefuls will be trained by a team of experts including
former Olympic triathlon coach, Barrie Shepley, and monitored by local
healthcare professionals.
“As a professional trainer and former Olympic triathlon coach, I take
asthma and other respiratory dysfunctions very seriously,” says Barrie
Shepley. “Typically, athletes with asthma are at a disadvantage compared to
competitors that do not live with this condition. In order to overcome this
disadvantage, athletes and their coaches should strive to learn as much as
possible about asthma in order to adapt the best training strategies and help
these athletes compete on a level playing field.”
While only a few participants will ultimately be selected for the Asthma
Marathon Challenge, everyone is encouraged to join the virtual team! A
self-managed marathon training program, designed by triathlon coach Barrie
Shepley, will be posted to the Ontario Lung Association Web site at
www.on.lung.ca. This is a great way for those not selected, or those not
living near a centre where teams are being formed, to take on the Asthma
Marathon Challenge and demonstrate that asthma need not restrict physical
activities.
To learn more about the marathon challenge or how to participate, please
visit www.on.lung.ca. Deadline for applications is February 2, 2007 by
5:00 p.m. Eastern Standard Time.
ATHLETE SPONSORSHIP
AstraZeneca is also proud to announce the three-year sponsorship of two
up-and-coming Canadian triathlon athletes, André-Paul Baillargeon-Smith and
Sean Bechtel, as they train for the Beijing 2008 and 2012 London Olympic
Games. Both André-Paul and Sean have been living with respiratory dysfunction
since childhood, yet have proven themselves to be two of the best triathletes
in Canada.
“The sponsorship initiative is an integral part of AstraZeneca’s vision
to contribute to Canadians’ health and quality of life through education and
health promotion,” says Kazi Borkowski, VP Medical Affairs, AstraZeneca
Canada. “Through this sponsorship, AstraZeneca strives to support André-Paul
and Sean as they pursue and fulfill their athletic goals. And, we believe, the
Asthma Marathon Challenge will contribute to Canadians’ understanding of
respiratory health and the importance of gaining and maintaining asthma
control.”
THE ONTARIO LUNG ASSOCIATION
The Lung Association is among Canada’s oldest voluntary, not-for-profit
health-promotion organizations. The Lung Association is concerned with the
prevention and control of asthma, chronic lung disease caused by smoking and
with air quality and its effect on lung health. The Ontario Lung Association
was incorporated in 1945, and has community offices across the province. Visit
the Ontario Lung Association on-line at www.on.lung.ca.
A
sthma care Canada was founded to enable people with asthma take control of their condition naturally and effectively without side effects. For further information visit www.asthmacare.ca or read our books Asthma Free naturally or Close Your Mouth.
Posted in Uncategorized | No Comments »
October 9th, 2006
PATRICK McARDLE, Staff Writer
Friday, October 6
BENNINGTON — After finding the incidence of sarcoidosis is 100 times higher than expected at the state office building, Vermont officials are planning to move all employees out of the building so it can be “diagnosed” and rehabilitated.
Commissioner of Health Sharon Moffatt and Commissioner of Buildings and General Services Tasha Wallis told employees in Bennington on Thursday they would probably move the first offices within about 30 days.
State office workers will be out of the building for a year or more, and in the meantime, the building will be renovated - with the expected major change being windows that open.
Moffatt said the decision did not mean there
State employees consider a report Thursday about the prevalence of sarcoidosis in the Bennington state office building on
Veterans Memorial Drive
. Photo by Peter Crabtree
was any evidence anything in the building was making people sick.
“We may never, and probably never will, know what the root cause is,” she said.
Moffatt said the decision to relocate the building was made after consulting with Wallis and Gov. James Douglas.
Wallis told about 40 workers who met in the Bennington District courtroom that a triple-wide, two-story trailer was expected to be brought to the site of the state office building in about two weeks. Moving furniture and equipment into the trailer, which will serve as space for the Department of Probation and Parole, is expected to take another two weeks.
The next stage in the move will be to relocate the courts and state’s attorney’s office to 15,000 square-feet at the Holden-Leonard Mill on
Benmont Avenue
.
Finally, the Agency of Human Services may be moved into 22,000 square feet at the Miller Manufacturing site on
Morse Road
.
Wallis gave an early estimate of $750,000 for relocating the workers.
The state was notified in June of an unusual number of cases of sarcoidosis among employees at the building. There have been at least six confirmed cases over a 15-year period.
Little is known about the causes of sarcoidosis, a relatively rare, noncommunicable disease, according to the National Institutes of Health. Its Web site said sarcoidosis “involves inflammation that produces tiny lumps of cells in various organs in (the) body. … If many (lumps) form in an organ, they can affect how the organ works.”
A person with sarcoidosis may not feel its effects so the disease often goes undiagnosed.
Employees at the state building are reporting major health issues, many with symptoms similar to sarcoidosis. A chart comparing health problems experienced in the last 12 months by the Bennington employees to 100 other buildings across the country showed much higher rates of respiratory problems, dry throat, fatigue and headaches.
People in the building reported asthma at rates about 60 percent higher than average Vermonters and 30 percent higher than others in Bennington.
The state office building includes two sections, one built in 1977 and another built in 1992. Workers in the older section, which is an L-shaped one-story structure, showed a greater incidence of symptoms like shortness of breath, nasal problems and back pain than those in the three-story “new section.”
The National Institute for Occupational Safety and Health conducted extensive pulmonary tests of building employees recently but results of those tests are not expected for another two to three weeks.
Wallis and Moffatt said they did not want to wait for further results when it was clear action needed to be taken. Their plan also includes hiring a firm that will conduct a complete diagnostic analysis of the building’s conditions and come up with a plan for the renovations.
At the announcement of the renovations to the office buildings windows, the audience burst into applause, the strongest reaction to anything said at the meeting.
Gretchen Naylor, senior representative of the Vermont State Employees Association whose coverage area includes Bennington, questioned Moffatt and Wallis closely about what firm will be hired to examine the building.
Wallis said there were at least three companies interested in performing the work and there had been discussions about hiring two of them to work simultaneously.
Naylor said the VSEA would like an independent, impartial firm recommended by the experts in the field of occupational health do the work.
“The VSEA is pleased the (commissioners) are doing the right thing and moving employees out of this building until further diagnostics can be done followed by a recommendation for renovations to make the building safe both for state employees and the general public,” Naylor said.
Wallis and Moffatt said the state was able to move as quickly as it did because of the cooperation of workers and coordination of Charlie Gingo, field director for the Agency of Human Services.
Gingo, who has worked at the building since 1980, said he had been pleased by a brief visit by Douglas to the state offices on Wednesday. The governor promised the process would be transparent and that the state would “do it right.”
Douglas told the workers he hadn’t received any complaints from his telephone or e-mail hotline about service suffering at the building because of the health concerns.
“There was a tremendous sense of relief (among workers) … People felt they were taken seriously and in some regard it was like, “Holy smokes!” Thirty or 45 days to do this fix-up, this move? I think it’s a surprise in a very positive way,” said Gingo.
Wallis said she couldn’t remember a similar situation of employees being taken out of a building because of health concerns with a plan to return them to the building.
She said the estimated $750,000, which doesn’t include the cost of building renovations, would likely be “squeezed” out of the Department of Buildings and General Service’s “Fee for Space” budget.
Moffatt and Wallis told employees on Thursday that despite the plan of action, they, or representatives of their departments will continue to meet with state office staff on a weekly basis to continue providing information.
Patrick McKeowns comments- teaching these workers to correct their hyperventilation by using the Buteyko method would have helped them significantly.
Posted in Uncategorized | No Comments »
October 9th, 2006
by Carolyn Pennington - October 9, 2006
Researchers at the UConn Health Center are studying whether an enzyme found in pineapples may offer relief for the millions of people who suffer from asthma.
Bromelain, extracted from the juice and stem of the pineapple plant, appears to reduce inflammation associated with asthma.
“Studies on bromelain go back to the 1950s,” says Dr. Eric Secor, a naturopathic physician and NIH Post Doctoral Fellow in the laboratory of Dr. Roger Thrall, Department of Immunology.
“But most of those initial studies looked at bromelain’s effectiveness on conditions such as arthritis, muscle contraction, or swelling.”
Secor’s research is focusing on bromelain’s impact on asthma and the immune system. Asthma rates may be stabilizing across the country but not in New England, where they continue to rise.
According to a recent study by the Asthma Regional Council, Connecticut has the highest rate of asthma among adults, at more than 15 percent.
Many turn to over-the-counter remedies for relief, which include herbs and nutritional supplements. Bromelain, especially popular in Europe, is typically taken in capsule or pill form, and millions of doses are sold every year.
Bromelain’s potency and popularity as a healing agent stems from a specific enzyme it contains that may have protective effects on a number of different ailments.
The pineapple extract has been used clinically as an anti-inflammatory agent in rheumatoid arthritis, soft tissue injuries, colonic inflammation, and chronic pain.
But along with most natural therapies, there are no definitive studies that prove its effectiveness.
“Bromelain is extremely popular, but my goal is to help determine whether it really is effective in treating asthma or are consumers just wasting their money,” says Secor.
In a study published in Cellular Immunology , Secor found bromelain treatment appeared to reduce the inflammation associated with asthma.
He and his research team tested three groups of mice that were induced with acute asthma: a control group, and two groups treated with either 2 mg or 6 mg of bromelain per kg.
All the mice were treated for four days.
The researchers found that bromelain significantly reduced the total white blood cell count, which increases with the onset of asthma, compared to the control group.
Furthermore, eosinophils, the main inflammatory cells associated with asthma, were reduced by more than 50 percent in the lungs of the mice following treatment with bromelain.
No such changes were seen among mice in the control group.
Since that first study, Secor has done several more experiments on different phases of the disease, for instance, an acute asthma model or a chronic model that shows bromelain’s effectiveness on mild to moderate symptoms.
He hopes these studies will help lay the foundation for human clinical trials.
Bromelain may work better for those with mild or moderate asthma symptoms, or it could be used in conjunction with prescription medications.
“Maybe it could cut down on steroid use – the standard treatment for asthma patients – and thus decrease the side effects sometimes seen with long-term steroid use,” Secor says.
But for now, he doesn’t see the pineapple extract being used as a primary treatment for asthma. “Asthma is a very serious disease. It can be life-threatening,” he says.
Posted in Uncategorized | 1 Comment »
« Previous Entries
|
